Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects (Q46601696)

From Wikidata
Jump to navigation Jump to search
scientific article published on 14 July 2005
edit
Language Label Description Also known as
English
Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects
scientific article published on 14 July 2005

    Statements

    Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects (English)
    0 references
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit